Details of the Drug

General Information of Drug (ID: DM1PI9G)

Drug Name
NN8717
Indication
Disease Entry ICD 11 Status REF
Graft-versus-host disease 4B24 Phase 3 [1]
Cross-matching ID
TTD ID
D0X3GA

Molecular Interaction Atlas of This Drug


Drug Therapeutic Target (DTT)
DTT Name DTT ID UniProt ID MOA REF
Coagulation factor XIII (F13B) TTAXGIP F13B_HUMAN Modulator [2]
Molecular Interaction Atlas (MIA) Jump to Detail Molecular Interaction Atlas of This Drug

References

1 Clinical pipeline report, company report or official report of Novo Nordisk A/S.
2 Topical recombinant thrombin at a concentration of 1000 IU/mL reliably shortens in vivo TTH and delivers durable hemostasis in the presence of heparin anticoagulation and clopidogrel platelet inhibition in a rabbit model of vascular bleeding. Ann Surg Innov Res. 2009; 3: 14.